Signaling pathways involved in cardiac energy metabolism

FEBS Letters

Volumn , Issue , 2016, Pages 2364-2374

  Chanda, Dipanjan ^a   Luiken, Joost J F P ^a   Glatz, Jan F C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

AMPK; CD36; GLUT4; insulin

Indexed keywords

ADENYLATE KINASE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CCAAT ENHANCER BINDING PROTEIN ALPHA; CD36 ANTIGEN; CYTOCHROME P450 2E1; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; INSULIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE LKB1; RAB PROTEIN; SIRTUIN 2;

ANTIGEN EXPRESSION; ENERGY METABOLISM; GENE EXPRESSION; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HEART CONTRACTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE METABOLISM; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 84981729588     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1002/1873-3468.12297     Document Type: Review

References (81)

1. Luiken JJ, Glatz JF and Neumann D (2015) Cardiac contraction-induced GLUT4 translocation requires dual signaling input. Trends Endocrinol Metab 26, 404–410.
2. Glatz JF, Nabben M, Heather LC, Bonen A and Luiken JJ (2016) Regulation of the subcellular trafficking of CD36, a major determinant of cardiac fatty acid utilization. Biochim Biophys Acta pii, S1388-1981(16)30104-4.
3. Lygate CA, Schneider JE and Neubauer S (2013) Investigating cardiac energetics in heart failure. Exp Physiol 98, 601–605.
4. Fillmore N and Lopaschuk GD (2013) Targeting mitochondrial oxidative metabolism as an approach to treat heart failure. Biochim Biophys Acta 1833, 857–865.
5. Klip A, Sun Y, Chiu TT and Foley KP (2014) Signal transduction meets vesicle traffic: the software and hardware of GLUT4 translocation. Am J Physiol Cell Physiol 306, C879–C886.
6. Glatz JF, Luiken JJ and Bonen A (2010) Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol Rev 90, 367–417.
7. Lopaschuk GD, Belke DD, Gamble J, Itoi T and Schonekess BO (1994) Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1213, 263–276.
8. Hue L and Taegtmeyer H (2009) The Randle cycle revisited: a new head for an old hat. Am J Physiol Endocrinol Metab 297, E578–E591.
9. Taegtmeyer H, Golfman L, Sharma S, Razeghi P and van Arsdall M (2004) Linking gene expression to function: metabolic flexibility in the normal and diseased heart. Ann N Y Acad Sci 1015, 202–213.
10. Joost HG and Thorens B (2001) The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members. Mol Membr Biol 18, 247–256.
11. Wood IS and Trayhurn P (2003) Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr 89, 3–9.
12. Hruz PW and Mueckler MM (2001) Structural analysis of the GLUT1 facilitative glucose transporter. Mol Membr Biol 18, 183–193.
13. Bryant NJ, Govers R and James DE (2002) Regulated transport of the glucose transporter GLUT4. Nat Rev Mol Cell Biol 3, 267–277.
14. Czech MP and Corvera S (1999) Signaling mechanisms that regulate glucose transport. J Biol Chem 274, 1865–1868.
15. Herman MA and Kahn BB (2006) Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J. Clin. Invest. 116, 1767–1775.
16. Rose AJ and Richter EA (2005) Skeletal muscle glucose uptake during exercise: how is it regulated? Physiology (Bethesda) 20, 260–270.
17. Watson RT, Kanzaki M and Pessin JE (2004) Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes. Endocr Rev 25, 177–204.
18. Thong FS, Dugani CB and Klip A (2005) Turning signals on and off: GLUT4 traffic in the insulin-signaling highway. Physiology (Bethesda) 20, 271–284.
19. Nandi A, Kitamura Y, Kahn CR and Accili D (2004) Mouse models of insulin resistance. Physiol Rev 84, 623–647.
20. Mitra P, Zheng X and Czech MP (2004) RNAi-based analysis of CAP, Cbl, and CrkII function in the regulation of GLUT4 by insulin. J Biol Chem 279, 37431–37435.
21. Zhou QL, Park JG, Jiang ZY, Holik JJ, Mitra P, Semiz S, Guilherme A, Powelka AM, Tang X, Virbasius J et al. (2004) Analysis of insulin signalling by RNAi-based gene silencing. Biochem Soc Trans 32, 817–821.
22. Vanhaesebroeck B and Alessi DR (2000) The PI3K–PDK1 connection: more than just a road to PKB. Biochem. J. 346, 561–576.
23. Sarbassov DD, Guertin DA, Ali SM and Sabatini DM (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098–1101.
24. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB 3rd, Kaestner KH, Bartolomei MS, Shulman GI and Birnbaum MJ (2001) Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292, 1728–1731.
25. Bae SS, Cho H, Mu J and Birnbaum MJ (2003) Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. J Biol Chem 278, 49530–49536.
26. Kane S, Sano H, Liu SC, Asara JM, Lane WS, Garner CC and Lienhard GE (2002) A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain. J Biol Chem 277, 22115–22118.
27. Zerial M and McBride H (2001) Rab proteins as membrane organizers. Nat Rev Mol Cell Biol 2, 107–117.
28. Sano H, Kane S, Sano E, Miinea CP, Asara JM, Lane WS, Garner CW and Lienhard GE (2003) Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem 278, 14599–14602.
29. Zeigerer A, McBrayer MK and McGraw TE (2004) Insulin stimulation of GLUT4 exocytosis, but not its inhibition of endocytosis, is dependent on RabGAP AS160. Mol Biol Cell 15, 4406–4415.
30. Gonzalez E and McGraw TE (2006) Insulin signaling diverges into Akt-dependent and -independent signals to regulate the recruitment/docking and the fusion of GLUT4 vesicles to the plasma membrane. Mol Biol Cell 17, 4484–4493.
31. Bai L, Wang Y, Fan J, Chen Y, Ji W, Qu A, Xu P, James DE and Xu T (2007) Dissecting multiple steps of GLUT4 trafficking and identifying the sites of insulin action. Cell Metab 5, 47–57.
32. Belman JP, Bian RR, Habtemichael EN, Li DT, Jurczak MJ, Alcázar-Román A, McNally LJ, Shulman GI and Bogan JS (2015) Acetylation of TUG protein promotes the accumulation of GLUT4 glucose transporters in an insulin-responsive intracellular compartment. J Biol Chem 290, 4447–4463.
33. Jessen N and Goodyear LJ (2005) Contraction signaling to glucose transport in skeletal muscle. J Appl Physiol 99, 330–337.
34. Kramer HF, Witczak CA, Fujii N, Jessen N, Taylor EB, Arnolds DE, Sakamoto K, Hirshman MF and Goodyear LJ (2006) Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle. Diabetes 55, 2067–2076.
35. Mu J, Brozinick JT Jr, Valladares O, Bucan M and Birnbaum MJ (2001) A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7, 1085–1094.
36. Hayashi T, Hirshman MF, Kurth EJ, Winder WW and Goodyear LJ (1998) Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47, 1369–1373.
37. Cleland PJ, Appleby GJ, Rattigan S and Clark MG (1989) Exercise-induced translocation of protein kinase C and production of diacylglycerol and phosphatidic acid in rat skeletal muscle in vivo. Relationship to changes in glucose transport. J Biol Chem 264, 17704–17711.
38. Dirkx E, Schwenk RW, Coumans WA, Hoebers N, Angin Y, Viollet B, Bonen A, van Eys GJ, Glatz JF and Luiken JJ (2012) Protein kinase D1 is essential for contraction-induced glucose uptake but is not involved in fatty acid uptake into cardiomyocytes. J Biol Chem 287, 5871–5881.
39. Luiken JJ, Vertommen D, Coort SL, Habets DD, El Hasnaoui M, Pelsers MM, Viollet B, Bonen A, Hue L, Rider MH et al. (2008) Identification of protein kinase D as a novel contraction-activated kinase linked to GLUT4-mediated glucose uptake, independent of AMPK. Cell Signal 20, 543–556.
40. Steinbusch LK, Dirkx E, Hoebers NT, Roelants V, Foretz M, Viollet B, Diamant M, van Eys G, Ouwens DM, Bertrand L et al. (2013) Overexpression of AMP-activated protein kinase or protein kinase D prevents lipid-induced insulin resistance in cardiomyocytes. J Mol Cell Cardiol 55, 165–173.
41. Dirkx E, van Eys GJ, Schwenk RW, Steinbusch LK, Hoebers N, Coumans WA, Peters T, Janssen BJ, Brans B, Vogg AT et al. (2014) Protein kinase-D1 overexpression prevents lipid-induced cardiac insulin resistance. J Mol Cell Cardiol 76, 208–217.
42. Farese RV, Sajan MP and Standaert ML (2005) Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): actions and defects in obesity and type II diabetes. Exp. Biol. Med. 230, 593–605.
43. Habets DD, Luiken JJ, Ouwens M, Coumans WA, Vergouwe M, Maarbjerg SJ, Leitges M, Bonen A, Richter EA and Glatz JF (2012) Involvement of atypical protein kinase C in the regulation of cardiac glucose and long-chain fatty acid uptake. Front Physiol 11, 361.
44. Sajan MP, Rivas J, Li P, Standaert ML and Farese RV (2006) Repletion of atypical protein kinase C following RNA interference-mediated depletion restores insulin-stimulated glucose transport. J Biol Chem 281, 17466–17473.
45. Liu ML, Olson AL, Moye-Rowley WS, Buse JB, Bell GI and Pessin JE (1992) Expression and regulation of the human GLUT4/muscle-fat facilitative glucose transporter gene in transgenic mice. J Biol Chem 267, 11673–11676.
46. Thai MV, Guruswamy S, Cao KT, Pessin JE and Olson AL (1998) Myocyte enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression in transgenic mice. Regulation of MEF2 DNA binding activity in insulin-deficient diabetes. J Biol Chem 273, 14285–14292.
47. Liu ML, Olson AL, Edgington NP, Moye-Rowley WS and Pessin JE (1994) Myocyte enhancer factor 2 (MEF2) binding site is essential for C2C12 myotube-specific expression of the rat GLUT4/muscle-adipose facilitative glucose transporter gene. J Biol Chem 269, 28514–28521.
48. Moreno H, Serrano AL, Santalucia T, Guma A, Canto C, Brand NJ, Palacin M, Schiaffino S and Zorzano A (2003) Differential regulation of the muscle-specific GLUT4 enhancer in regenerating and adult skeletal muscle. J Biol Chem 278, 40557–40564.
49. Santalucia T, Moreno H, Palacin M, Yacoub MH, Brand NJ and Zorzano A (2001) A novel functional co-operation between MyoD, MEF2 and TRalpha1 is sufficient for the induction of GLUT4 gene transcription. J Mol Biol 314, 195–204.
50. Oshel KM, Knight JB, Cao KT, Thai MV and Olson AL (2000) Identification of a 30-base pair regulatory element and novel DNA binding protein that regulates the human GLUT4 promoter in transgenic mice. J Biol Chem 275, 23666–23673.
51. Knight JB, Eyster CA, Griesel BA and Olson AL (2003) Regulation of the human GLUT4 gene promoter: interaction between a transcriptional activator and myocyte enhancer factor 2A. Proc Natl Acad Sci USA 100, 14725–14730.
52. Armoni M, Kritz N, Harel C, Bar-Yoseph F, Chen H, Quon MJ and Karnieli E (2003) Peroxisome proliferator-activated receptor-gamma represses GLUT4 promoter activity in primary adipocytes, and rosiglitazone alleviates this effect. J Biol Chem 278, 30614–30623.
53. Buchner DA, Charrier A, Srinivasan E, Wang L, Paulsen MT, Ljungman M, Bridges D and Saltiel AR (2015) Zinc finger protein 407 (ZFP407) regulates insulin-stimulated glucose uptake and glucose transporter 4 (Glut4) mRNA. J Biol Chem 290, 6376–6386.
54. Armoni M, Harel C, Ramdas M and Karnieli E (2014) CYP2E1 impairs GLUT4 gene expression and function: NRF2 as a possible mediator. Horm Metab Res 46, 477–483.
55. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS and Stanley WC (2010) Myocardial fatty acid metabolism in health and disease. Physiol Rev 90, 207–258.
56. Abumrad NA, el-Maghrabi MR, Amri EZ, Lopez E and Grimaldi PA (1993) Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 268, 17665–17668.
57. Schwenk RW, Dirkx E, Coumans WA, Bonen A, Klip A, Glatz JF and Luiken JJ (2010) Requirement for distinct vesicle-associated membrane proteins in insulin- and AMP-activated protein kinase (AMPK)-induced translocation of GLUT4 and CD36 in cultured cardiomyocytes. Diabetologia 53, 2209–2219.
58. Samovski D, Su X, Xu Y, Abumrad NA and Stahl PD (2012) Insulin and AMPK regulate FA translocase/CD36 plasma membrane recruitment in cardiomyocytes via Rab GAP AS160 and Rab8a Rab GTPase. J Lipid Res 53, 709–717.
59. Steinbusch LK, Schwenk RW, Ouwens DM, Diamant M, Glatz JF and Luiken JJ (2011) Subcellular trafficking of the substrate transporters GLUT4 and CD36 in cardiomyocytes. Cell Mol Life Sci 68, 2525–2538.
60. Luiken JJ, Dyck DJ, Han XX, Tandon NN, Arumugam Y, Glatz JF and Bonen A (2002) Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane. Am J Physiol Endocrinol Metab 282, E491–E495.
61. Ouwens DM, Diamant M, Fodor M, Habets DD, Pelsers MM, El Hasnaoui M, Dang ZC, van den Brom CE, Vlasblom R, Rietdijk A et al. (2007) Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification. Diabetologia 50, 1938–1948.
62. Luiken JJ, Ouwens DM, Habets DD, van der Zon GC, Coumans WA, Schwenk RW, Bonen A and Glatz JF (2009) Permissive action of protein kinase C-zeta in insulin-induced CD36- and GLUT4 translocation in cardiac myocytes. J Endocrinol 201, 199–209.
63. Ronnebaum SM and Patterson C (2010) The FoxO family in cardiac function and dysfunction. Annu Rev Physiol 72, 81–94.
64. Luiken JJ, Coort SL, Willems J, Coumans WA, Bonen A, van der Vusse GJ and Glatz JF (2003) Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes 52, 1627–1634.
65. Philip-Couderc P, Tavares NI, Roatti A, Lerch R, Montessuit C and Baertschi AJ (2008) Forkhead transcription factors coordinate expression of myocardial KATP channel subunits and energy metabolism. Circ Res 102, e20–e35.
66. Samovski D, Sun J, Pietka T, Gross RW, Eckel RH, Su X, Stahl PD and Abumrad NA (2015) Regulation of AMPK activation by CD36 links fatty acid uptake to beta-oxidation. Diabetes 64, 353–359.
67. Habets DD, Coumans WA, Voshol PJ, den Boer MA, Febbraio M, Bonen A, Glatz JF and Luiken JJ (2007) AMPK-mediated increase in myocardial long-chain fatty acid uptake critically depends on sarcolemmal CD36. Biochem Biophys Res Commun 355, 204–210.
68. Angin Y, Schwenk RW, Nergiz-Unal R, Hoebers N, Heemskerk JW, Kuijpers MJ, Coumans WA, van Zandvoort MA, Bonen A, Neumann D et al. (2014) Calcium signaling recruits substrate transporters GLUT4 and CD36 to the sarcolemma without increasing cardiac substrate uptake. Am J Physiol Endocrinol Metab 307, E225–E236.
69. Irie H, Krukenkamp IB, Brinkmann JF, Gaudette GR, Saltman AE, Jou W, Glatz JF, Abumrad NA and Ibrahimi A (2003) Myocardial recovery from ischemia is impaired in CD36-null mice and restored by myocyte CD36 expression or medium-chain fatty acids. Proc Natl Acad Sci USA 100, 6819–6824.
70. Pietka TA, Sulkin MS, Kuda O, Wang W, Zhou D, Yamada KA, Yang K, Su X, Gross RW, Nerbonne JM et al. (2012) CD36 protein influences myocardial Ca2+ homeostasis and phospholipid metabolism: conduction anomalies in CD36-deficient mice during fasting. J Biol Chem 287, 38901–38912.
71. Kim TT and Dyck JR (2015) Is AMPK the savior of the failing heart?. Trends Endocrinol Metab 26, 40–48.
72. Cheung L, Andersen M, Gustavsson C, Odeberg J, Fernández-Pérez L, Norstedt G and Tollet-Egnell P (2007) Hormonal and nutritional regulation of alternative CD36 transcripts in rat liver – a role for growth hormone in alternative exon usage. BMC Mol Biol 8, 60.
73. Qiao L, Zou C, Shao P, Schaack J, Johnson PF and Shao J (2008) Transcriptional regulation of fatty acid translocase/CD36 expression by CCAAT/enhancer-binding protein alpha. J Biol Chem 283, 8788–8795.
74. Mwaikambo BR, Yang C, Chemtob S and Hardy P (2009) Hypoxia up-regulates CD36 expression and function via hypoxia-inducible factor-1- and phosphatidylinositol 3-kinase-dependent mechanisms. J Biol Chem 284, 26695–26707.
75. Motojima K, Passilly P, Peters JM, Gonzalez FJ and Latruffe N (1998) Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. J Biol Chem 273, 16710–16714.
76. Teboul L, Febbraio M, Gaillard D, Amri EZ, Silverstein R and Grimaldi PA (2001) Structural and functional characterization of the mouse fatty acid translocase promoter: activation during adipose differentiation. Biochem J 360, 305–312.
77. Maxwell MA, Cleasby ME, Harding A, Stark A, Cooney GJ and Muscat GEO (2005) Nur77 regulates lipolysis in skeletal muscle cells. Evidence for cross-talk between the beta-adrenergic and an orphan nuclear hormone receptor pathway. J Biol Chem 280, 12573–12584.
78. Ishii T, Itoh K, Ruiz E, Leake DS, Unoki H, Yamamoto M and Mann GE (2004) Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ Res 94, 609–616.
79. Coppiello G, Collantes M, Sirerol-Piquer MS, Vandenwijngaert S, Schoors S, Swinnen M, Vandersmissen I, Herijgers P, Topal B, van Loon J et al. (2015) Meox2/Tcf15 heterodimers program the heart capillary endothelium for cardiac fatty acid uptake. Circulation 131, 815–826.
80. Andersen M, Lenhard B, Whatling C, Eriksson P and Odeberg J (2006) Alternative promoter usage of the membrane glycoprotein CD36. BMC Mol Biol 7, 8.
81. Love-Gregory L, Sherva R, Schappe T, Qi JS, McCrea J, Klein S, Connelly MA and Abumrad NA (2011) Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile. Hum Mol Genet 20, 193–201.